Axsome Therapeutics Inc (AXSM)
99.56
-0.92
(-0.92%)
USD |
NASDAQ |
Dec 04, 16:00
99.40
-0.16
(-0.17%)
After-Hours: 20:00
Axsome Therapeutics Profit Margin (Quarterly): -61.67% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -61.67% |
| June 30, 2024 | -91.03% |
| March 31, 2024 | -91.14% |
| December 31, 2023 | -137.9% |
| September 30, 2023 | -107.6% |
| Date | Value |
|---|---|
| June 30, 2023 | -143.8% |
| March 31, 2023 | -11.86% |
| December 31, 2022 | -251.3% |
| September 30, 2022 | -266.1% |
| June 30, 2022 | -469.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-469.8%
Minimum
Jun 2022
-11.86%
Maximum
Mar 2023
-163.2%
Average
-122.8%
Median
Profit Margin (Quarterly) Benchmarks
| Repligen Corp | -0.42% |
| Pfizer Inc | 25.22% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -194.3% |
| Return on Assets | -54.66% |
| Return on Invested Capital | -91.79% |
| Gross Profit Margin (Quarterly) | 91.95% |
| Operating Margin (Quarterly) | -44.13% |
| Return on Net Operating Assets | -164.7% |